FindTrial
Sign In

Study of children having symptoms of stomach contents rising into the esophagus.

Clinical Profile Of Gastroesophageal Reflux Disease In Children and Its Associated Comorbidities - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/07/055893
Enrollment
103
Registered
2023-07-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

Intervention1: nil: nil

Sponsors

SAINATH GHALI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children with clinically suspected gastroesophageal reflux disease aged between 1 month and 60 months of age

Exclusion criteria

Exclusion criteria: Children already diagnosed to have gastroesophageal reflux disease prior to inclusion and on medication for Gastroesophageal reflux

Design outcomes

Primary

MeasureTime frame
Primary Outcome: Will be assessed at follow up to view severity of disease, compliance with treatment , weight gain or loss. A 6 month follow up is recommended for children with GER as part of standard careTimepoint: A 6 month follow up is recommended for children with GER as part of standard care.—

Secondary

MeasureTime frame
Severity of symptoms of Gastroesophageal reflux will be assessed at 6 month follow upTimepoint: child will be followed up at 6 month of the study—

Countries

India

Contacts

Public ContactDr Sandesh Kini

Kasturba Medical College, Manipal

sandesh.kini@manipal.edu9731149519

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026